Globally, non-communicable diseases (NCDs) are the leading cause of morbidity and mortality, including in the WHO European region. Within this region, the Member States with the greatest cardiovascular disease (CVD) burden are also some of the lowest resourced. As the need for technical support for the implementation of essential CVD/NCD interventions in primary healthcare (PHC) in these regions grew urgent, the WHO Regional Office for Europe has been directly supporting national governments in the development, assessment, scale-up and quality improvement of large scale PHC interventions for CVD. Herein, we synthesise the key learnings from providing technical support to national governments under the auspices of the WHO across the European region and share these learnings as a resource for public health professionals to consider when increasing coverage of quality essential health services. Based on our experience providing technical support to a diversity of Member States in the European Region (eg, Tajikistan, Republic of Moldova, Ukraine and Uzbekistan), we have identified six key lessons: prioritising NCDs for public health intervention, identifying and mapping existing resources, engaging key stakeholders, tailoring interventions to the local health system, generating local evidence and ensuring quality improvement while mainstreaming. Common challenges across all phases of implementation include multiple and inconsistent international toolkits and guidance, lack of national capacity for evidence-based healthcare, limited access to essential medicines and technologies, inconsistent national guidelines and limited experience in evaluation methodology, clinical epidemiology and guideline implementation. We map the lessons to the Consolidated Framework for Implementation Research and highlight key learnings and challenges specific to the region. Member States in the region are at various stages of implementation; however, several are currently conducting pragmatic clinical trials to generate local evidence for health policy. As this work expands, greater engagement with peer-to-peer sharing of contextual wisdom, sharing of resources, publishing methodology and results and development of region-specific resources is planned.
- cardiovascular disease
- public health
- health systems
This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Statistics from Altmetric.com
This Practice article is intended for those involved in the implementation of primary healthcare interventions for the prevention and management of cardiovascular disease risk in settings with a high disease burden and limited resources.
Working under the auspices of the WHO Regional Office for Europe to support Member States at a national level, we synthesise our six key learnings from a breadth of projects and settings from Eastern Europe and Central Asia.
We map these lessons to the Consolidated Framework for Implementation Research which is useful in that the framework is a validated tool that allows national governments to predict and plan around factors known to be influential for implementation and successfully increasing access to quality essential health services.
Common challenges include multiple and inconsistent international toolkits and guidance, lack of national capacity for evidence-based healthcare, limited access to essential medicines and technologies, inconsistent national guidelines and limited experience in evaluation methodology, clinical epidemiology and guideline implementation.
Globally, non-communicable diseases (NCDs) are the leading cause of morbidity and mortality, including in the WHO European region.1 In this region, premature mortality is decreasing in every Member State where good data exist, making most Member States on track to meet Sustainable Development Goal 3.4 (a reduction in premature mortality from the four major NCDs by one third by 2030).2 The leading causes of premature mortality are cardiovascular diseases (CVDs), a group of conditions which are largely preventable.2 Low and lower-middle income countries are disproportionately affected by NCDs and therefore represent an important target for public health intervention.3
The WHO European region is a highly diverse group of Member States, ranging from Western Europe (eg, Portugal) to the Eastern Parts of Central Asia (eg, Tajikistan), including the Russian Federation (table 1).4 Eastern European and Central Asian countries are on average one to two generations behind the rest of the European Region with respect to avoidable NCD mortality, and the main source of premature mortality from NCDs is CVD.2 This is attributed to excess male CVD mortality in the East, largely because of high rates of smoking and alcohol use, non-engagement with health services and gender norms that discourage engagement with healthcare.5 Furthermore, while average blood pressure has decreased significantly in many regions of the world, Member States in Central Asian and Eastern Europe have not realised these gains and average blood pressure in these jurisdictions remains among the highest in the world.6
The Member States with the greatest CVD burden are also some of the lowest resource jurisdictions in the WHO European region.2 For this reason, a pragmatic approach to implementation focusing on the evidence-based use of resources is essential to maximise the probability of improving national health outcomes within limited resources. Many evidence-based interventions for the prevention and management of CVD are also cost-effective (<US$100 per DALY averted). These include both clinical interventions (eg, drug therapy for primary prevention for those at high CVD risk, including diabetes and secondary prevention) and policy interventions (eg, increased taxation of alcohol and tobacco, elimination of secondhand smoke exposure, front-of-pack salt labelling).7 Herein, we focus more on the implementation of clinical interventions, but it should be noted that a sustainable and effective health system response includes both clinical and policy-level change, for which there are evidenced-based, cost-effective options for low resource settings.7
While primary healthcare (PHC) is the cornerstone of achieving universal health coverage and provides better outcomes at lower cost for NCDs, many former Soviet republics have underdeveloped primary and public health systems which are specialist driven and struggle to train and retain PHC physicians.8 9 This is in part because historically, soviet PHC services concentrated on dealing with infectious diseases, antenatal care and lacked longitudinal care for patients with chronic conditions. Soviet PHC in rural areas was provided by a team consisting of a nurse, midwife and feldsher (physician’s assistant) and in urban areas, narrow specialists provided primary care in ‘polyclinics’.9 Following independence, former Soviet Union States have deviated from this model to varying degrees, some choosing to develop specialty training programmes for family medicine (eg, Moldova) which has bolstered PHC.9
It is within this context of disease burden and nascent PHC that the need for technical support from the WHO Regional Office for Europe for the implementation of essential CVD/NCD interventions by former Soviet republics became more urgent. In our capacity providing technical support to Member States under the auspices of the WHO, herein we synthesise the key learnings from working with national governments across the European region and share these learnings as a resource for public health professionals to consider when implementing quality essential CVD risk interventions.
A practical approach for low-resource settings in Eastern Europe and Central Asia
The work and progress of the WHO European Region has provided insight into the unique considerations when implementing essential interventions for CVD risk management in PHC. These considerations are drawn from Member States at various stages of implementation, with varying interpretations of international guidance, and in diverse health systems.10–12 Still, through such a breadth of contexts, we have identified six key lessons for future jurisdictions to consider. We map these to the Consolidated Framework for Implementation Research (CFIR) and highlight key learnings and challenges specific to the region (tables 2 and 3).13 Case box 1 shows examples of key lessons in action.
Key lessons in action in the Republic of Moldova, Ukraine, Uzbekistan and Tajikistan
The following are examples of key lessons in action from across Central Asia and Eastern Europe, chosen to illustrate the breadth and scale of improving access to quality essential health services.
Generating evidence for decision making in the Republic of Moldova
In the Republic of Moldova, a year-long cluster randomised pilot implementation and mixed methods evaluation was designed in order to optimise essential interventions for NCDs in PHC and to determine the feasibility of measuring their effectiveness using routine clinical data. This was part of a project cofunded by WHO and the Swiss Agency for Development and Cooperation (SDC) and was done with a view towards national scale-up with systems for monitoring, evaluation and continuous quality improvement. This approach also aimed to build national capacity in research methodology, monitoring and evaluation and to pioneer methodology and research instruments which could be used in other settings.25
Developing appropriate and effective trainings for family doctors in Ukraine
As part of a project cofunded by WHO and SDC, a country-context-specific package of Essential Training on the Integrated Management of Hypertension and Diabetes was developed with the support of WHO during 2016, drawing on existing national materials as international guidance. This was piloted and evaluated, then used for a cascaded training of trainers. By March 2018, 8000 PHC workers in seven pilot regions had completed the training package and received simple clinical decision support tools such as desktop laminated cards with risk prediction tools. The impact of the training on clinical practice will be assessed using mixed methods.26
Integrating with undergraduate medical education in Tajikistan
In Tajikistan, national clinical guidelines were adapted to include the WHO/ISH risk prediction chart and simple clinical protocols were developed based on WHO PEN. With the cofunding and support of WHO, a national team in Tajikistan then developed a 2-day training for family doctors and nurses in using the tools for CVD risk assessment and management, including control of diabetes and hypertension. This training in the use of protocols and risk prediction charts has also been introduced into the university undergraduate curricula and postgraduate studies.27
Combining implementation with continuous quality improvement in Uzbekistan
As part of a WHO/World Bank-supported project, primary care facilities in two regions in Uzbekistan adapted and implemented the WHO PEN package of clinical protocols, supported by community-level interventions to facilitate change in risk factor behaviours. Over 12 months, the intervention led to greater coverage of the target population and improved detection and control of cardiovascular risk factors, as well as increasing the engagement of men in NCD prevention.28 Both family doctors and nurses received training and support leading to better organisation of care, increased task-sharing between doctors and nurses and enhanced the role of nurses in PHC. The intervention included regular monitoring of key performance indicators through audits of case records, observed clinical practice and interviews with patients and practitioners on a quarterly basis, with timely feedback and clinical supervision.
NCDs, non-communicable diseases; PHC, primary healthcare.
Lesson One: Prioritise non-communicable diseases for public health intervention using local data
Despite international and regional targets for meaningful reductions in premature NCD morbidity and mortality, public health interventions need to be prioritised based on local evidence and distributions of disease burden.14 The WHO STEPwise Approach to Non-communicable Disease Risk Factor Surveillance (WHO STEPS) is a standardised, freely available methodology which enumerates the burden of disease and risk factors in a population.15 This information can be used to prioritise specific conditions (eg, CVD) and risk factors (eg, raised blood pressure), build a case for public health intervention and establish a baseline to monitor trends over time. In our experience, the use of nation-specific epidemiological data can improve the implementation climate, build a tension for change and increase the relative priority of NCDs for public health intervention (table 3).13 Additionally, collection of these data also allow for meta-epidemiological comparisons between populations, allowing health systems to compare their performance to other populations and systems.
Lesson Two: Identify and map appropriate existing national and international resources
While there are many freely available resources for implementing essential NCD interventions in PHC (see examples in table 2), these resources were developed to be broadly generalisable to health systems. As such, no single resource is sufficient nor appropriate for direct implementation. Furthermore, given that many health systems are under-resourced, it is wise to use pre-exiting materials when possible. We therefore recommend a process of deconstructing and combining the best components of multiple existing resources into a ‘draft intervention package’. When mapping the components of existing resources, several aspects known to influence implementation should be examined. These include the intervention source (perception of whether the intervention is externally or internally developed), the evidence strength and quality (both literal and perceived), relative advantage compared with an alternate intervention, adaptability (the degree to which the intervention can be adapted), the ability to test the intervention, complexity, cost and compatibility with the medical culture (table 3).13
Lesson Three: Engage key stakeholders from inception to mainstreaming
Many Member States in the WHO European Region have relatively underdeveloped PHC systems and nascent family medicine training programmes.16 Because of this, there is a risk of under-engagement with PHC workers in the development of PHC, in what is often largely a specialist-driven climate. Recognising frontline PHC workers (including physicians, nurses, managers and allied health professionals) as key stakeholders can help assess the basic assumptions of the programme, the need and capacity for change, the perceived relative priority of the programme, advice on reallocation of resources and clinical tasks and identify leaders to aid in championing change (table 3).13 Furthermore, recognising patients and the public as stakeholders can help align programme goals and structure so as to increase the chance of implementation success.13
Lesson Four: Tailor intervention to local health system
Before piloting to generate local evidence of effectiveness (Lesson Five), the draft intervention using existing resources should be tailored to suit the local health system, with a specific view towards sustainability. While there may be a bias to promote international best practice, this desire needs to be balanced with pragmatism to ensure that if effective, it can actually be implemented in PHC. Key considerations include the access and availability of medicines included in newly developed guidelines, the training and skills of PHC workers, referral networks to secondary and tertiary care, the availability of laboratory testing and the capacity of health informatics to register, record, remind and recall patients. It is important to also examine the resources available to conduct training of healthcare workers, the availability of clinical decision support tools (such as printed one-page clinical algorithms), the capacity to perform patient education with relevant printed health education materials and how tasks can be shared between physician and non-physician health workers (table 3).13
Lesson Five: Generate local evidence of effectiveness
The generation of local evidence of effectiveness through pragmatic clinical trials is an essential step that helps to identify factors affecting successful implementation, including: intervention source, evidence strength and quality, relative advantage, complexity, cost, implementation climate, compatibility, knowledge and beliefs of the intervention and engagement of health workers and academics through training and capacity building (table 3).13 Importantly, gathering local evidence early in health systems development allows for the potential of deadoption if the intervention is not effective, causes harm or is unlikely to be sustainable. Some freely available resources are available to help conduct pragmatic trials, including open-source R Software for WHO/ISH risk scores,17 the CFIR,13 the WHO Framework for Operations and Implementation Research in Health and Disease Control Programs,18 published examples of mixed methods evaluations in low-resource settings19 and clear methodological guidance on qualitative research.20
Lesson Six: Ensure continuous quality improvement while mainstreaming
If the decision is made to mainstream interventions throughout the PHC system, implementation success is in part built on the ability to provide quantitative and qualitative feedback in a timely and effective way to frontline staff.13 Scaling too quickly and without quality improvement infrastructure such as peer-to-peer support, clinical audit training, quality circles, knowledge of plan-do-study-act cycles, runs the risk of sacrificing quality of care for widespread scale-up.
Achievement of universal healthcare and reduction of premature CVD mortality require functioning PHC systems that increase coverage of quality essential health services. Immense effort has gone into developing free, open-source, evidence-based guidelines and public policy packages; however, implementation remains challenging. We therefore hope that by mapping our six key lessons to validated CFIR domains, this will help national governments to predict and plan around factors known to be influential for the improving access to quality essential health services. While Member States in the region are at various stages of implementation, several are currently conducting pragmatic cluster randomised trials to generate local evidence for health policy that will help add to the implementation science evidence base.21 22 As this work expands, greater engagement with peer-to-peer sharing of contextual wisdom, sharing of resources and publishing methodology and results and development of region-specific resources is planned. This includes organising workshops that bring together Member States to share their experiences and build organic communities of practices and to build capacity for implementation research.23 By building capacity for implementation research, the hope is that Member States will be better prepared to conduct and communicate their findings in open access journals and share their experiences even beyond their own communities of practice. From these initial workshops with 13 Member States, a specific need has been identified for region-specific resources for training of PHC workers, including the identification of key clinical competencies and a core learning outcome set. Future work includes highlighting the importance and leadership and organisational structures that support implementation, including the allocation of proper resources. This includes how projects can be mainstreamed in a sustainable way without reductions in quality.
Staff of the WHO Country Offices in Ukraine, Republic of Moldova, Tajikistan, Uzbekistan, national authorities, development partners who contributed to specific projects referred to financially and technically (World Bank, Swiss Government/SDC) and donors (Russian Federation).
Handling editor Seye Abimbola
Contributors DC, TL and JF conceptualised and wrote the manuscript. All authors agreed on the final version.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent for publication Not required.
Provenance and peer review Not commissioned; externally peer reviewed.
Data availability statement There are no data to share.
Author note JF is a staff member of the World Health Organization. JF alone is responsible for the views expressed in this publication and they do not necessarily represent the views, decisions or policies of the World Health Organization.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.